Search PubMedSearch

Biomedical subjects

V N Trieu

Publications and source records attributed to V N Trieu.

6 recordsLinked to original sources

Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.

Recombinant DNA-derived apolipoprotein(a) was used to demonstrate that the apo(a) moiety of lipoprotein(a) (Lp(a)) is responsible for the binding of Lp(a) to other apolipoprotein B-containing lipoproteins (apoB-Lp) including LDL2, a subclass of low density lipoproteins (d = 1.030-1.063 g/ml). The r-apo(a).LDL2 complexes exhibited the same binding constant as Lp(a).LDL2 (10(-8) M). Treatment of either recombinant apo(a) or Lp(a) with a reducing agent destroyed binding activity. A synthetic polypeptide corresponding to a portion of apo(a)'s kringle-4 inhibited the binding (K1 = 1.9 x 10(-4) M) of LDL2 to Lp(a). Therefore, we concluded that binding to apoB-Lp was mediated by the kringle-4-like domains on apo(a). Using ligand chromatography which can detect complexes having a KD as low as 10(-2) M, we demonstrated the binding of plasminogen to apoB-Lp. Like Lp(a), binding of plasminogen to apoB-Lp was mediated by the kringle domain(s). The differences in binding affinity may be due to amino acid substitutions in the kringle-4-like domain. In most of the kringle-4-like domains of apo(a), the aspartic residue critical for binding to lysine was substituted by valine. Consistent with this substitution, we found that L-proline and hydroxyproline, but not L-lysine, inhibited the binding of LDL2 to apo(a). Inhibition by L-proline could be reversed in the binding studies by increasing the amount of apo(a); and L-proline-Sepharose bound plasma Lp(a), suggesting that L-proline acted as a ligand for the kringle-4-like domain(s) of apo(a) involved in the binding of apoB-Lp. The binding of apo(a) to proline and hydroxyproline could be responsible for the binding of apo(a) to the subendothelial extracellular matrix, i.e. domains of proteins rich in proline or hydroxyproline (e.g. collagen and elastin).

Amino Acids

Lp(a) interactions.

In this report, we have summarized our recent studies on lipoprotein(a) (Lp(a)) and its interactions with apolipoprotein B-containing lipoproteins (ApoB-Lp). These findings implicate the kringle-4-like domains of Apo(a) in the binding of Lp(a) to other ApoB-Lp and point to proline as important in this interaction. Other studies have indicated that Lp(a) interacts with the subendothelial extracellular matrix (ECM) and that Lp(a) is inversely related to plasma triglycerides. Since Apo(a) also has an affinity for ApoB-Lp, enhanced binding of Apo(a) to the arterial wall could increase the accumulation of LDL in the matrix and thus promote the development of cardiovascular disease.

Apolipoproteins A

Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins.

A method combining ligand dot blotting and digital imaging was used to determine the apparent dissociation constant (KD) for the binding of lipoprotein(a) to low-density lipoproteins (Lp(a)-LDL2). By use of this approach, the KD for the Lp(a)-LDL2 complex was shown to be in the nanomolar range [(1.05 +/- 0.21) x 10(-8) M, n = 4]. The Lp(a)-LDL2 interaction was both hydrophobic and ionic; however, hydrophobic forces predominated because the interaction was demonstrable at high salt concentration (greater than 2 M NaCl), while no complex was detectable at low salt concentration (less than 0.08 M NaCl). Consistent with the hydrophobic nature of this interaction, the Lp(a)-LDL2 complex was stable over a wide pH range (4-10). Plasminogen did not compete with Lp(a) binding to LDL2 even at a 2.2 X 10(3) molar excess of plasminogen over the LDL2 concentration. The only component identified in plasma and serum that inhibited the binding of LDL2 to Lp(a) was apolipoprotein B containing lipoproteins (apoB-Lp). These studies indicate that the Lp(a)-LDL2 complex could exist in plasma. In fact, up to 72% of purified Lp(a) added to an Lp(a)-negative hypertriglyceridemic plasma floated with apoB-Lp (d less than 1.063 g/mL) following ultracentrifugation, whereas only 9% of the purified Lp(a) added to the apoB-Lp-free 1.12 g/mL infranate floated at d less than 1.063 g/mL. The formation of a complex of Lp(a) with apoB-Lp could increase the amount of cholesterol ester bound per cellular receptor, e.g., LDL receptor, and thus potentially accelerate cholesterol removal from the vascular compartment.

Animals

Improved plasmid shuttle vectors for Haemophilus influenzae and Escherichia coli.

In vitro deletion and transposon mutagenesis experiments were performed to localize the region essential for plasmid RSF0885 replication to a 1.7-kb sequence downstream from the beta-lactamase gene. This locus was named rep, for replication. Plasmid RSF0885 can replicate in both Haemophilus influenzae and Escherichia coli. Replication in E. coli depended on transcription run-off from the beta-lactamase promoter into the rep locus. Insufficient transcription into the rep locus could account for the instability of this plasmid in an E. coli background, a property which reduced its usefulness as a shuttle vector. Therefore, four improved shuttle vectors for H. influenzae and E. coli were constructed. They possess the Co1E1 replication origin for maintenance in E. coli and the plasmid RSF0885 rep locus for maintenance in H. influenzae. Together, they provide twelve unique restriction sites for cloning by insertional inactivation of drug-resistance genes.

DNA Replication

Lp(a) and plasma triglyceride-rich lipoproteins.

Based on our studies showing an interaction between Lp(a) and ApoB-containing lipoproteins (ApoB-Lp) and the observation that the interacting ApoB-Lp were somewhat enriched in triglyceride (TG), we have initiated studies to explore this potential relationship of Lp(a) and TG-rich lipoproteins. In exploring Lp(a)'s incidence in hypertriglyceridemic subjects, we found a significantly reduced incidence (31%, p less than 0.05) of Lp(a) levels greater than 9 mg/ml when compared to both normolipidemic (61%) and subjects with coronary heart disease (49%). Analyses of a second group of hypertriglyceridemic subjects (n = 68) demonstrated that only 15% of subjects with TG greater than 400 mg/dl (n = 20) had levels of Lp(a) greater than 9 mg/dl while 52% of those with TG levels less than 400 mg/dl (n = 48) had this level of detectable Lp(a). These studies point to an inverse relationship between plasma TG and Lp(a) levels.

Coronary Disease

Identification of Escherichia coli DNA helicase IV with the use of a DNA helicase activity gel.

A DNA helicase activity gel was developed based on the assumption that DNA helicases could unwind double-stranded DNA in a polyacrylamide matrix. The production of single-stranded DNA was detected by staining the activity gel with acridine orange and visualizing the gel under long-wave UV light. The products of DNA helicase activities appeared as red bands within a green fluorescent background. A novel DNA helicase, called helicase IV, was detected in crude extracts of Escherichia coli with the use of the helicases activity gel assay. The new DNA helicase was purified to near homogeneity. The chromatographic properties and the sequence of its 11 amino-terminal residues proved that helicase IV was distinct from all of the previously described DNA helicases from E. coli.

Amino Acid Sequence